The Pipeline Center

Filter Your Results

 

News

 

Retina News

October 2018—Apellis Begins PHASE 3 Trials FOR COMPLEMENT INHIBITION in GA Two phase 3 trials of a complement-inhibiting peptide have begun, assessing the safety and efficacy of the com…

Retina News

September 2018—Aflibercept Label Now Includes 12-Week Dosing Interval for AMD The US FDA in August approved an updated label for aflibercept (Eylea, Regeneron), adding every-12-week injec…

Retina News

July/August 2018—NOVARTIS PLANS TO SPIN OFF ALCON Novartis plans to spin off its eye care devices division, Alcon, into a separately traded standalone company, the company announced in June…

Topical Drug Delivery for Retinal Disease Management

David S. Boyer, MD

July/August 2018—The cornea and sclera stand in the way of this more convenient, less invasive drug delivery modality.

Less Invasive Treatment for Uveitis

Glenn J. Jaffe, MD

July/August 2018—An injectable sustained drug delivery system may have advantages over existing options.

A Long-Term Treatment Option for AMD?

An interview with Carl D. Regillo, MD

July/August 2018—A principal investigator for a surgically implanted port delivery system talks about the device’s design and performance in patients with wet AMD.

Retina News

May/June 2018—Ablate-and-Replace Gene Therapy Was Successful in Mouse Model of RP An approach to gene therapy in which a gene editing tool is used to delete a mutated gene and replace it…

Opinion: Paving the Way to Accessible Treatment for All

Thomas Ciulla, MD, MBA

March 2018—Gene therapy offers promise but poses a challenge to current payment models.

 

This Month's Supplements

 
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman
Editor-in-Chief
484-581-1827
kroman@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.